• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 18
  • 16
  • 12
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

4
5
47
52

PUBLISHED

0
9
27
52

PRODUCT TYPE

49
3

Search "Emergent BioSolutions, Inc.-Therapeutic Competitors" returned 52 results.

Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review

Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2015
FROM
Competitor Analysis: Anthrax Vaccines & Therapeutics Competitor Analysis: Anthrax Vaccines & Therapeutics - Product Thumbnail Image

Competitor Analysis: Anthrax Vaccines & Therapeutics

The Competitive Intelligence Report Anthrax Vaccines & Therapeutics as of June 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of...

June 2013
FROM
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

March 2014
FROM

Hemophilia A - Pipeline Review, H1 2015

Hemophilia A - Pipeline Review, H1 2015 Summary This, ‘Hemophilia A - Pipeline Review, H1 2015’, provides an overview of the Hemophilia A’s therapeutic pipeline. This report provides comprehensive...

June 2015
FROM

Anthrax - Pipeline Review, H1 2015

Anthrax - Pipeline Review, H1 2015 Summary This, ‘Anthrax - Pipeline Review, H1 2015’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive information on...

January 2015
FROM

Anthrax - Pipeline Review, H2 2014

Anthrax - Pipeline Review, H2 2014 Summary This, ‘Anthrax - Pipeline Review, H2 2014’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive information on...

November 2014
FROM

Pandemic Influenza - Pipeline Review, H1 2015

Pandemic Influenza - Pipeline Review, H1 2015 Summary This, ‘Pandemic Influenza - Pipeline Review, H1 2015’, provides an overview of the Pandemic Influenza’s therapeutic pipeline. This report provides...

January 2015
FROM

Hemophilia B - Pipeline Review, H1 2015

Hemophilia B - Pipeline Review, H1 2015 Summary This, ‘Hemophilia B - Pipeline Review, H1 2015’, provides an overview of the Hemophilia B’s therapeutic pipeline. This report provides comprehensive...

May 2015
FROM

Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015

Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015 Summary This, ‘Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015’, provides an overview of the Burkholderia Pseudomallei...

May 2015
FROM

Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014

Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014 Summary This, ‘Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014’, provides an overview of the Burkholderia Pseudomallei...

December 2014
FROM

Typhoid Fever - Pipeline Review, H1 2014

Typhoid Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline. This report...

March 2014
FROM

Indolent Lymphoma - Pipeline Review, H1 2015

Indolent Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This report provides...

January 2015
FROM

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM

Indolent Lymphoma - Pipeline Review, H1 2014

Indolent Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This...

April 2014
FROM

Follicular Lymphoma - Pipeline Review, H1 2015

Follicular Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This report...

June 2015
FROM

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014 Summary This, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014’, provides an overview of the Respiratory...

July 2014
FROM

Indolent Lymphoma - Pipeline Review, H2 2014

Indolent Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Indolent Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This report provides...

October 2014
FROM

H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014

H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014 Summary This, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014’, provides an overview of the H5N1 Infection (Avian Influenza)’s...

November 2014
FROM

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015 Summary This, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015’, provides an overview of the H5N1 Infection (Avian Influenza)’s...

June 2015
FROM

Inflammatory Bowel Disease - Pipeline Review, H2 2014

Inflammatory Bowel Disease - Pipeline Review, H2 2014 Summary This, ‘Inflammatory Bowel Disease - Pipeline Review, H2 2014’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline. This...

November 2014
FROM
Loading Indicator

Our Clients

Walgreen's Company Elanco Global Nu Skin Enterprises Kemin Industries, Inc. Suan Farma Inc. Metagenics, Inc.